NovaBay Pharmaceuticals Inc (NYSE American:NBY)

3.40
Delayed Data
As of Feb 23
 0.00 / 0.00%
Today’s Change
2.25
Today|||52-Week Range
5.00
-11.69%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Revenue and IncomeNet Revenues4.1M3.7M4.1M4.1M
 
 
 
 
 
Cost of Goods Sold792.0K570.0K680.0K503.0K
 
 
 
 
 
Depreciation And Amortization16.0K18.0K18.0K18.0K
 
 
 
 
 
 
Operating ExpensesGross Income3.3M3.1M3.4M3.6M
 
 
 
 
 
General Expenses5.3M6.9M5.2M5.7M
 
 
 
 
 
Research And Development156.0K62.0K70.0K132.0K
 
 
 
 
 
Total Operating Expenses6.1M7.5M5.9M6.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-2.0M-3.8M-1.8M-2.2M
 
 
 
 
 
Extraordinary Credit381.0K--15.0K0.00
 
 
 
Extraordinary Charge---235.0K---281.0K
 
 
 
Other Expenses1.0K2.0K4.0K3.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-1.6M-4.0M-1.7M-2.4M
 
 
 
 
 
Income Taxes0.00-1.0K0.000.00
 
 
Net Income-1.6M-4.0M-1.7M-2.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS15.1M15.3M15.3M15.3M
 
 
 
 
 
Shares To Calculate EPS Diluted15.5M15.3M15.3M15.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.13-$0.26-$0.11-$0.16
 
 
 
 
 
EPS Diluted-$0.11-$0.26-$0.11-$0.16